2ml semaglutide Flex-Dose 2 mL Injectable 2.5 mg/mL Semaglutide: Injection Home Kit –

The Glucagon Like Peptide-1 (GLP-1) receptor agonist, exenatide, has been shown to significantly reduce ICP in IIH, therefore this study aimed to determine the effects of exenatide on cognition in IIH

This claim appears to have emerged from anecdotal reports on social media and online forums, but it is not supported by clinical trials, peer-reviewed research, or regulatory documentation from the MHRA, European Medicines Agency (EMA), or manufacturer's prescribing information

On the other hand, SCFAs can protect the BBB directly or indirectly through anti-inflammatory mechanisms

- Tolerance mismatch: Users may tolerate sedation but not respiratory effects, increasing overdose risk